Vision for future Studies

The first phase of the EDCTP will end in 2014. We are very hopeful that there will be an EDCTP II as well as a PanACEA II. The former, we hope, will be budgeted with €1 billion to expedite the next stage of clinical trials in poverty-related diseases. For a prospective PanACEA II, €50 million…

Read more Vision for future Studies

PanACEA Studies

PanACEA has a strong history of well conducted clinical trials to evaluate new regimens for the treatment of drug sensitive TB. Our studies range from small two-center early Phase IIA studies through to large-scale Phase III studies in a multitude of sites and countries. At the start of the consortium, separate development programmes were conducted…

Read more PanACEA Studies